These compounds may interact with:
Cyclin-dependent kinase 1
Potentially involved in: type 2 diabetes mellitus; cancer; neuronal ceroid lipofuscinosis; liver cirrhosis, experimental; diffuse large b-cell lymphoma; drug-induced paranoid state; adrenocortical carcinoma; adult high grade glioma; astrocytoma; astrocytoma, pilocytic; atopic dermatitis; atypical teratoid / rhabdoid tumor; breast cancer; breast carcinoma; colon cancer; ductal carcinoma in situ; endometriosis; ependymoma; esophageal adenocarcinoma; glioblastoma
Disease data sourced from Pharos.